There was no significant difference of TCF21 expression between stage I and stage II ovarian cancer, but TCF21 expression significantly decreased in stage III and stage IV compared to stage I ovarian cancer (Fig. 3a). The gene discussed is TCF21; the disease is ovarian carcinoma.